about
Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplifi...
Read More
2.58
-0.02
(-0.77%)
9,538.2
XNAS Volume
XNAS 06 Oct, 2026 11:10 AM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Boundless Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..